154 related articles for article (PubMed ID: 26476533)
1. Naringin suppresses the metabolism of A375 cells by inhibiting the phosphorylation of c-Src.
Guo B; Zhang Y; Hui Q; Wang H; Tao K
Tumour Biol; 2016 Mar; 37(3):3841-50. PubMed ID: 26476533
[TBL] [Abstract][Full Text] [Related]
2. Glycolytic inhibitor 2-deoxy-d-glucose suppresses cell proliferation and enhances methylprednisolone sensitivity in non-Hodgkin lymphoma cells through down-regulation of HIF-1α and c-MYC.
Pang YY; Wang T; Chen FY; Wu YL; Shao X; Xiao F; Huang HH; Zhong H; Zhong JH
Leuk Lymphoma; 2015 Jun; 56(6):1821-30. PubMed ID: 25219592
[TBL] [Abstract][Full Text] [Related]
3. Gambogic acid induces apoptosis by regulating the expression of Bax and Bcl-2 and enhancing caspase-3 activity in human malignant melanoma A375 cells.
Xu X; Liu Y; Wang L; He J; Zhang H; Chen X; Li Y; Yang J; Tao J
Int J Dermatol; 2009 Feb; 48(2):186-92. PubMed ID: 19200201
[TBL] [Abstract][Full Text] [Related]
4. CXCR7 promotes melanoma tumorigenesis via Src kinase signaling.
Xu S; Tang J; Wang C; Liu J; Fu Y; Luo Y
Cell Death Dis; 2019 Feb; 10(3):191. PubMed ID: 30804329
[TBL] [Abstract][Full Text] [Related]
5. PKM2 contributes to cancer metabolism.
Wong N; Ojo D; Yan J; Tang D
Cancer Lett; 2015 Jan; 356(2 Pt A):184-91. PubMed ID: 24508027
[TBL] [Abstract][Full Text] [Related]
6. Ribosomal protein L11- and retinol dehydrogenase 11-induced erythroid proliferation without erythropoietin in UT-7/Epo erythroleukemic cells.
Kummalue T; Inoue T; Miura Y; Narusawa M; Inoue H; Komatsu N; Wanachiwanawin W; Sugiyama D; Tani K
Exp Hematol; 2015 May; 43(5):414-423.e1. PubMed ID: 25829192
[TBL] [Abstract][Full Text] [Related]
7. Src activates HIF-1α not through direct phosphorylation of HIF-1α specific prolyl-4 hydroxylase 2 but through activation of the NADPH oxidase/Rac pathway.
Lee HY; Lee T; Lee N; Yang EG; Lee C; Lee J; Moon EY; Ha J; Park H
Carcinogenesis; 2011 May; 32(5):703-12. PubMed ID: 21335603
[TBL] [Abstract][Full Text] [Related]
8.
; ; . PubMed ID: 19810018
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]